Agilon Health (AGL)
(Delayed Data from NYSE)
$3.52 USD
-0.35 (-9.04%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $3.52 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Income Statements
Fiscal Year end for Agilon Health, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 4,316 | 2,708 | 1,834 | 1,218 | 794 |
Cost Of Goods | 4,247 | 2,596 | 1,757 | 1,124 | 766 |
Gross Profit | 70 | 112 | 76 | 94 | 29 |
Selling & Adminstrative & Depr. & Amort Expenses | 302 | 233 | 470 | 151 | 135 |
Income After Depreciation & Amortization | -232 | -120 | -394 | -57 | -107 |
Non-Operating Income | 44 | 19 | -5 | 2 | 1 |
Interest Expense | 7 | 5 | 6 | 8 | 9 |
Pretax Income | -194 | -106 | -405 | -62 | -115 |
Income Taxes | 1 | 2 | 1 | 1 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -195 | -107 | -405 | -63 | -114 |
Extras & Discontinued Operations | -68 | 0 | -1 | 3 | -168 |
Net Income (GAAP) | -263 | -107 | -406 | -60 | -283 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -212 | -107 | -379 | -43 | -65 |
Depreciation & Amortization (Cash Flow) | 20 | 14 | 15 | 14 | 41 |
Income After Depreciation & Amortization | -232 | -120 | -394 | -57 | -107 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 408.92 | 408.15 | 372.93 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.46 | -0.26 | -0.36 | NA | NA |
Diluted Net EPS (GAAP) | -0.64 | -0.26 | -1.09 | -0.19 | NA |
Fiscal Year end for Agilon Health, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 1,482.76 | 1,604.35 | 815.50 | 1,215.66 | 1,149.05 |
Cost Of Goods | 1,450.58 | 1,529.27 | 910.80 | 1,185.18 | 1,091.86 |
Gross Profit | 32.18 | 75.09 | -95.30 | 30.48 | 57.19 |
SG&A, R&D, and Dept/Amort Expenses | 75.52 | 82.26 | 64.31 | 79.45 | 87.02 |
Income After SG&A, R&D, and Dept/Amort Expenses | -43.34 | -7.17 | -159.61 | -48.97 | -29.83 |
Non-Operating Income | 14.80 | 11.58 | -1.18 | 20.35 | 15.69 |
Interest Expense | 1.70 | 1.28 | 1.89 | 1.65 | 1.59 |
Pretax Income | -30.25 | 3.11 | -162.67 | -30.27 | -15.72 |
Income Taxes | 0.42 | -0.13 | 0.27 | 1.21 | 1.07 |
Minority Interest | 0.02 | 0.03 | -0.05 | -0.05 | -0.05 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -30.66 | 3.25 | -162.93 | -31.48 | -16.80 |
Extras & Discontinued Operations | 0.00 | -9.28 | -63.35 | 0.00 | 0.00 |
Net Income (GAAP) | -30.68 | -6.06 | -230.43 | -31.44 | -16.75 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 411.27 | 413.44 | 406.48 | 405.79 | 410.34 |
Diluted EPS Before Non-Recurring Items | -0.07 | 0.01 | -0.41 | -0.06 | -0.04 |
Diluted Net EPS (GAAP) | -0.07 | -0.02 | -0.56 | -0.08 | -0.04 |